Showing results (191-200 of 1,831) with videos related to
Sort By:
Pageof 184
ESMO Open|November 21, 2023
The association of clinical and patient factors with chemotherapy-induced peripheral neuropathy (CIPN) in colorectal cancer: secondary analysis of the SCOT trialA Lemanska, A Harkin, T Iveson, et al.ESMO Open|January 17, 2024
Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysisT Landré, A Karaboué, Z S Buchwald, et al.ESMO Open|December 29, 2023
ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2023Tanja Cufer, Michael P Kosty, ESMO Open|December 15, 2023
Discontinuation rate and serious adverse events of chemoimmunotherapy as neoadjuvant treatment for triple-negative breast cancer: a systematic review and meta-analysisA Rizzo, F M Schipilliti, F Di Costanzo, et al.ESMO Open|March 16, 2024
REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastomaM Caccese, I Desideri, V Villani, et al.ESMO Open|July 26, 2024
Inhibitor of apoptosis proteins (IAP) inhibitor APG-1387 monotherapy or in combination with programmed cell death 1 (PD-1) inhibitor toripalimab in patients with advanced solid tumors: results from two phase I trialsF-R Liu, X-L Wei, W-N Feng, et al.ESMO Open|July 17, 2024
Phase II study of brigatinib in patients with ROS1 fusion-positive non-small-cell lung cancer: the Barossa studyS Niho, Y Goto, R Toyozawa, et al.ESMO Open|July 13, 2024
A first-in-human phase I study of a novel MDM2/p53 inhibitor alrizomadlin in advanced solid tumorsX Zhang, X Wen, R Peng, et al.ESMO Open|July 27, 2024
Association between health-related quality-of-life results, outcomes of efficacy and drug approvals: a meta-research study of randomized phase III trials in oncologyC Paratore, C Zichi, R Schiavone, et al.Pageof 184